Ghrelin and anterior pituitary function

Frontiers of Hormone Research

Volumn 38, Issue , 2010, Pages 206-211

  Lanfranco, Fabio ^a   Motta, Giovanna ^a   Baldi, Matteo ^a   Gasco, Valentina ^a   Grottoli, Silvia ^a   Benso, Andrea ^a   Broglio, Fabio ^a   Ghigo, Ezio ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CORTICOTROPIN RELEASING FACTOR; GHRELIN; GONADOTROPIN; GROWTH HORMONE; NALOXONE; OPIATE ANTAGONIST; PROLACTIN;

ADENOHYPOPHYSIS; HUMAN; HYPOPHYSIS CELL; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN FUNCTION; REVIEW;

ADRENOCORTICOTROPIC HORMONE; CORTICOTROPIN-RELEASING HORMONE; GHRELIN; GONADOTROPINS; GROWTH HORMONE-RELEASING HORMONE; HUMANS; PITUITARY GLAND, ANTERIOR; PROLACTIN;

EID: 84926112143     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000318512     Document Type: Review

References (38)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K: Ghrelin is a growth-hormone acy-lated peptide from stomach. Nature 1999;402:656-660.
2. Kojima M, Hosoda H, Matsuo H, Kangawa K: Ghrelin: discovery of the natural endogenous ligand for the growth hormone secretagogue receptor. Trends Endocrinol Metab 2001;12:118-122. (Pubitemid 33714199)
3. Kojima M, Kangawa K: Ghrelin: structure and function. Physiol Rev 2005;85:495-522.
4. Van der Lely AJ, Tschöp M, Heiman ML, Ghigo E: Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 2004;25:426-457.
5. Ghigo E, Broglio F, Arvat E, Maccario M, Papotti M, Muccioli G: Ghrelin: more than a natural GH secre-tagogue and/or an orexigenic factor. Clin Endocrinol 2005;62:1-17.
6. Broglio F, Prodam F, Riganti F, Muccioli G, Ghigo E: Ghrelin: from somatotrope secretion to new perspectives in the regulation of peripheral metabolic functions. Front Horm Res 2006;35:102-114.
7. Sun Y, Ahmed S, Smith RG: Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003;23:7973-7981.
8. Arvat E, Di Vito L, Broglio F, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E: Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 2000;23:493-495.
9. Goth MI, Lyons CE, Canny BJ, Thorner MO: Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 1992;130:939-944.
10. Smith RG, Cheng K, Schoen WR, Pong SS, Hickey G, Jacks T, Butler B, Chan WW, Chaung LY, Judith F: A nonpeptidyl growth hormone secretagogue. Science 1993;260:1640-1643.
11. Clark RG, Carlsson MS, Trojnar J, Robinson IC: The effects of a growth hormone-releasing peptide and growth hormone-releasing factor in conscious and anaesthetized rats. J Neuroendocrinol 1989;1:249-255.
12. Bowers CY, Sartor AO, Reynolds GA, Badger TM: On the actions of the growth hormone-releasing hexa-peptide, GHRP. Endocrinology 1991;128:2027-2035.
13. Barkan AL, Dimaraki E V, Jessup SK, Symons KV, Ermolenko M, Jaffe CA: Ghrelin secretion in humans is sexually dimorphic, suppressed by soma-tostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 2003;88: 2180-2184.
14. Ghigo E, Arvat E, Giordano R, Broglio F, Gianotti L, Maccario M, Bisi G, Graziani A, Papotti M, Muccioli G, Deghenghi R, Camanni F: Biologic activities of growth hormone secretagogues in humans. Endocrine 2001;14:87-93.
15. Broglio F, Benso A, Castiglioni C, Gottero C, Prodam F, Destefanis S, Gauna C, Van Der Lely AJ, Deghenghi R, Bo M, Arvat E, Ghigo E: The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endo-crinol Metab 2003;88:1537-1542.
16. Zizzari P, Halem H, Taylor J, Dong JZ, Datta R, Culler MD, Epelbaum J, Bluet-Pajot MT: Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology 2005; 146:3836-3842.
17. Ghigo E, Arvat E, Aimaretti G, Broglio F, Giordano R, Camanni F: Diagnostic and therapeutic uses of growth hormone-releasing substances in adult and elderly subjects. Baillieres Clin Endocrinol Metab 1998;12:341-358.
18. Bowers CY: On a peptidomimetic growth hormone-releasing peptide. J Clin Endocrinol Metab 1994; 79:940-942.
19. Arvat E, Maccario M, Di Vito L, Broglio F, Benso A, Gottero C, Papotti M, Muccioli G, Dieguez C, Casanueva FF, Deghenghi R, Camanni F, Ghigo E: Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001;86:1169-1174.
20. Arvat E, Ramunni J, Bellone J, Di Vito L, Baffoni C, Broglio F, Deghenghi R, Bartolotta E, Ghigo E: The GH, prolactin, ACTH and cortisol responses to hexarelin, a synthetic hexapeptide, undergo different age-related variations. Eur J Endocrinol 1997; 137:635-642.
21. Korbonits M, Little JA, Forsling ML, Tringali G, Costa A, Navarra P, Trainer PJ, Grossman AB: The effect of growth hormone secretagogues and neuro-peptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol 1999;11:521-528.
22. Mozid AM, Tringali G, Forsling ML, Hendricks MS, Ajodha S, Edwards R, Navarra P, Grossman AB, Korbonits M: Ghrelin is released from rat hypotha-lamic explants and stimulates corticotrophin-releas-ing hormone and arginine-vasopressin. Horm Metab Res 2003;35:455-459.
23. Arvat E, Giordano R, Ramunni J, Arnaldi G, Colao A, Deghenghi R, Lombardi G, Mantero F, Camanni F, Ghigo E: Adrenocorticotropin and cortisol hyper-responsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. J Clin Endocrinol Metab 1998;83:4207-4211.
24. Leal-Cerro A, Torres E, Soto A, Dios E, Deghenghi R, Arvat E, Ghigo E, Dieguez C, Casanueva FF: Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses. Neuroendocrinology 2002;76: 390-396.
25. Barlier A, Zamora AJ, Grino M, Gunz G, Pellegrini-Bouiller I, Morange-Ramos I, Figarella-Branger D, Dufour H, Jaquet P, Enjalbert A: Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies. J Neuroendocrinol 1999;11:491-502.
26. Martínez-Fuentes AJ, Moreno-Fernández J, Vázquez-Martínez R, Durán-Prado M, De La Riva A, Tena-Sempere M, Diéguez C, Jiménez-Reina L, Webb SM, Pumar A, Leal-Cerro A, Benito-López P, Malagón MM, Castaño JP: Ghrelin is produced by and directly activates corticotrope cells from adre-nocorticotropin-secreting adenomas. J Clin Endo-crinol Metab 2006;91:2225-2231.
27. Furuta M, Funabashi T, Rimura F: Intracerebro-ventricular administration of ghrelin rapidly suppresses pulsatile luteinizing hormone secretion in ovariectomized rats. Biochem Biophys Res Commun 2001;288:780-785.
28. Tena-Sempere M, Barreiro ML, Gonzalez LC, Gaytan F, Zhang FP, Caminos JE, Pinilla L, Casa-nueva FF, Dieguez C, Aguilar E: Novel expression and functional role of ghrelin in rat testis. Endocrinology 2002;143:717-725.
29. Kawamura K, Sato N, Fukuda J, Kodama H, Kumegai J, Tanikawa H, Nakamura A, Honda Y, Sato T, Tanaka T: Ghrelin inhibits the development of mouse preimplantation embryos in vitro. Endocrinology 2003;144:2623-2633. (Pubitemid 36629915)
30. Barreiro ML, Tena-Sempere M: Ghrelin and reproduction: a novel signal linking energy status and fertility? Mol Cell Endocrinol 2004;226:1-9.
31. Fernández-Fernández R, Tena-Sempere M, Aguilar E, Pinilla L: Ghrelin effects on gonadotropin secretion in male and female rats. Neurosci Lett 2004;362: 103-107.
32. Vulliémoz NR, Xiao E, Xia-Zhang L, Germond M, Rivier J, Ferin M: Decrease in luteinizing hormone pulse frequency during a five-hour peripheral ghre-lin infusion in the ovariectomized rhesus monkey. J Clin Endocrinol Metab 2004;89:5718-5723.
33. Fernández-Fernández R, Tena-Sempere M, Navarro VM, Barreiro ML, Castellano JM, Aguilar E, Pinilla L: Effects of ghrelin upon gonadotropin-releasing hormone and gonadotropin secretion in adult female rats: in vivo and in vitro studies. Neuro-endocrinology 2005;82:245-255. (Pubitemid 43800871)
34. Iqbal J, Kurose Y, Canny B, Clarke IJ: Effects of central infusion of ghrelin on food intake and plasma levels of growth hormone, luteinizing hormone, prolactin, and cortisol secretion in sheep. Endocrinology 2006;147:510-519.
35. Lanfranco F, Bonelli L, Baldi M, Me E, Broglio F, Ghigo E: Acylated ghrelin inhibits spontaneous LH pulsatility and responsiveness to naloxone, but not that to GnRH in young men: evidence for a central inhibitory action of ghrelin on the gonadal axis. J Clin Endocrinol Metab 2008;93:3633-3639.
36. Vanhorebeek I, Langouche L, Van den Berghe G: Endocrine aspects of acute and prolonged critical illness. Nat Clin Pract Endocrinol Metab 2006;2:20-31.
37. Broglio F, Gianotti L, Destefanis S, Fassino S, Abbate Daga G, Mondelli V, Lanfranco F, Gottero C, Gauna C, Hofland L, Van der Lely AJ, Ghigo E: The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol 2004;60:592-599.
38. Shimizu Y, Nagaya N, Isobe T, Imazu M, Okumura H, Hosoda H, Kojima M, Kangawa K, Kohno N: Increased plasma ghrelin level in lung cancer cachexia. Clin Cancer Res 2003;9:774-778.